The US Food and Drug Administration (FDA) approved the Renaissance surgical guidance system for brain and spinal surgery, manufactured by Israeli company Mazor Robotics Ltd.
Mazor recently improved the system to allow it to work for brain surgery, reported Globes. The units only performing spinal surgery cost $750,000 each. Mazor had NIS 9.2 million in sales for the first quarter of 2012.
The company also hopes to get approval for the marketing of the system for brain surgery in Europe, where it is currently only approved for spinal surgery procedures.
Related posts:
Minister explains Australia's Defence shake up
BlackBerry maker RIM sued by NXP over patents
FBI Pushes Congress to Legislate ISPs to Install Backdoor Programs for Surveillance
Yahoo names three new independent directors to board
Get a Program, Get Organized, and Get Active
Dozens wounded, arrested in IOF quelling of Bilin conference